Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |